Kliničke studije za ХОБП u državi Пенсилванија
33 studija za ХОБП traži učesnike na lokacijama u državi Пенсилванија.
Gradovi u državi Пенсилванија
Zvanični tekst studije (na engleskom)
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50002, DuBois
Тражи се учесникФаза 2
Узраст од 40 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Clinical Research Associates of Central PA, DuBois
Тражи се учесникФаза 2
Узраст од 40 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07759245Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Penn Highlands - Lung Innovations/Clinical Research Associates, DuBois
- Temple University - Temple Lung Center, Philadelphia
- University of Pittsburgh Medical Center - UMPC Comprehensive Lung Center, Pittsburgh
Тражи се учесник
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 11. 2026. · NCT07051707WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Temple University Hospital, Philadelphia
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research Associates of Central PA, LLC, DuBois
- DM Clinical Research - Philadelphia, Philadelphia
Тражи се учесникФаза 2
Узраст од 40 до 85 · Оба пола · Ажурирано 28. 10. 2026. · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, DuBois
- Research Site, Philadelphia
- и још 3
Тражи се учесникФаза 2
Узраст 40 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Suburban Research Associates - Media- Site Number : 8400143, Media
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, DuBois
Тражи се учесникФаза 2
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Research Associates of Central PA, LLC, DuBois
- Temple University Hospital, Philadelphia
- Temple Health Oaks, Phoenixville
Тражи се учесникФаза 2/3
Узраст од 35 до 80 · Оба пола · Ажурирано 22. 10. 2026. · NCT07363694A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Clinical Research Associates of Central Pennsylvania- Site Number : 8400002, DuBois
Тражи се учесникФаза 4
Узраст од 40 до 85 · Оба пола · Ажурирано 20. 10. 2026. · NCT07053423Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Clinical Research Associates of Central Pennsylvania, DuBois
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
Тражи се учесник
Узраст од 40 до 84 · Оба пола · Ажурирано 19. 10. 2026. · NCT06891755Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Temple University Hospital- Site Number : 8400059, Philadelphia
- Preferred Primary Care Physicians - Pleasant Hills- Site Number : 8400092, Pittsburgh
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 19. 10. 2026. · NCT07190209STRIVE Post-Market Registry Study
- Penn State Milton S. Hershey Medical Center, Hershey
- Temple University, Philadelphia
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT04302272A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Horsham
- Research Site, Pittsburgh
- Research Site, Sayre
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 9. 10. 2026. · NCT06878261Emphysema Research Registry and Biosample Repository
- University of Pittsburgh Emphysema/COPD Research Center, Pittsburgh
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 21 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT00307281Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
Тражи се учесникЗдраве особе су добродошле
Узраст од 8 до 70 · Оба пола · Ажурирано 5. 10. 2026. · NCT06512064Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 10. 2026. · NCT06961214A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, Philadelphia
- Research Site, Philadelphia
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 2. 10. 2026. · NCT06283966An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
- Allegheny General Hospital, Pittsburgh
- и још 1
Тражи се учесник
Узраст од 40 до 80 · Оба пола · Ажурирано 17. 9. 2026. · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Temple University, Philadelphia
- University of Pittsburgh, Pittsburgh
Тражи се учесникФаза 2
Узраст 40 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, DuBois
- Research Site, Philadelphia
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 3. 9. 2026. · NCT06883305COPD Exacerbation Follow Up
- Thomas Jefferson University, Philadelphia
Тражи се учесникОпсервациона студија
Узраст 40 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT07118306Multi-Center Clean Air Randomized Controlled Trial in COPD
- Reading Hospital, West Reading
Тражи се учесникФаза 3
Узраст 40 и старији · Оба пола · Ажурирано 31. 7. 2026. · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, DuBois
- GSK Investigational Site, West Chester
Тражи се учесникФаза 3
Узраст од 40 до 75 · Оба пола · Ажурирано 28. 7. 2026. · NCT07177339Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Temple University Hospital, Philadelphia
Тражи се учесник
Узраст 22 и старији · Оба пола · Ажурирано 23. 6. 2026. · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Temple University, Philadelphia
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 30 до 55 · Оба пола · Ажурирано 3. 6. 2026. · NCT05033990Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 21. 4. 2026. · NCT05746039Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
- Thomas Jefferson University, Philadelphia
Тражи се учесникОпсервациона студија
Узраст од 50 до 80 · Оба пола · Ажурирано 3. 3. 2026. · NCT06974981Supporting Evidence-based Responses to Emotional Needs in Emphysema
- University of Pennsylvania, Philadelphia
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 30. 1. 2026. · NCT06600126Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- UPMC Presbyterian, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Тражи се учесникФаза 1/2
Узраст од 18 до 60 · Оба пола · Ажурирано 13. 1. 2026. · NCT03500731Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Clinical Research Associates of Central PA, DuBois
- US Digestive Health at Lancaster, Lancaster
- Temple University, Philadelphia
- и још 2
Тражи се учесникОпсервациона студија
Узраст 50 и старији · Оба пола · Ажурирано 5. 8. 2025. · NCT06122077Temple Health Chest Initiative (THCI 2.0)
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 50 до 80 · Оба пола · Ажурирано 18. 4. 2025. · NCT06933758myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- St. Luke's University Health Network, Bethlehem
- Clinical Research Associates of Central Pennsylvania, DuBois
- Jeanes Hospital, Philadelphia
- и још 2
Тражи се учесник
Узраст 30 и старији · Оба пола · Ажурирано 6. 2. 2025. · NCT05204888Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.